Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 4
Submit an article Journal homepage
216
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropneia in patients with hematological malignancies

Akihito ShinoharaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Yumiko YoshikiDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Yosuke MasamotoDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Akira HangaishiDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Yasuhito NannyaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
&
Mineo KurokawaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, JapanCorrespondence[email protected]
Pages 794-798 | Received 30 Apr 2012, Accepted 22 Aug 2012, Published online: 02 Jan 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Elio Castagnola, Malgorzata Mikulska, Paola Barabino, Ines Lorenzi, Riccardo Haupt & Claudio Viscoli. (2013) Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on. Expert Opinion on Emerging Drugs 18:3, pages 263-278.
Read now
Gabrielle M. Haeusler & Monica A. Slavin. (2013) Fluoroquinolone prophylaxis: worth the cost?. Leukemia & Lymphoma 54:4, pages 677-678.
Read now

Articles from other publishers (1)

Daniel J. Przybylski & David J. Reeves. (2017) Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy. Supportive Care in Cancer 25:12, pages 3715-3721.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.